Clinical and molecular neuro-oncology research (Neuro-Oncology Parallel Session)
Tracks
Strauss 2-3
| Tuesday, October 7, 2025 |
| 8:00 AM - 9:30 AM |
Speakers & Chairs
Mehdi Touat
Chair
Nikolaos Foroglou
Chair
Malte Mohme
Neuro-Immune Crosstalk – Evolutionary immunosuppression in trauma and cancer
8:00 AM - 8:10 AM
Joonas Haapasalo
CSF liquid biopsy diagnostics in brain tumors
8:10 AM - 8:20 AM
Mehdi Touat
PCV or temozolomide with radiotherapy in IDH-mutant 1p/19q-codeleted grade 3 oligodendrogliomas
8:20 AM - 8:30 AM
Prof. Tao Xu
Vice Chairman Of Neurosurgery
Changzheng Hospital
Defect-Engineered 2D Black Ferroelectric Perovskite Nanocatalysts for Augmented Piezocatalytic Glioma Therapy
8:30 AM - 8:37 AM
Dr Manina Etter
Resident
University Hospital
Combating Glioblastoma: Enhancing anti-EGFRvIII CAR T Cell Therapy with a Paracrine SIRP -derived CD47 Blocker – A Proof-of-Concept Preclinical Study Translating into a First-in-Human Phase I Clinical Trialac
8:37 AM - 8:44 AM
Dr Jonas Ort
Resident
Rwth Aachen University
Glioblastoma cell infiltration induces neuronal hyperexcitability and alters peritumoral network connectivity properties in an in-vitro model of human brain slice cultures.
8:44 AM - 8:51 AM
Ms. Angelica Patterson
PhD Student
HOCH Health Ostschweiz
The Intra-humoral Heterogeneity of the Antigenic Landscape in Glioblastoma
8:51 AM - 8:58 AM
Dr Harald Krenzlin
Attending
Uksh Lübeck
Interim analysis of the International IM4 Study: Clinical course of primary IDH-mutant astrocytoma CNS-WHO grade 4 and formerly known primary IDH-mutant glioblastoma WHO grade IV
8:58 AM - 9:05 AM
Dr Eduardo Erasmo Mendoza Mireles
Specialist
Oslo University Hospital
A International Multicenter Cohort Study of Surgery for Recurrent Brain Metastases (RECMET) – An EANS Section of Neuro-Oncology Initiative
9:05 AM - 9:12 AM
Mr Carlos Aude
Medical Student
Johns Hopkins University School of Medicine
Glucagon-Like Peptide-1 Receptor Agonists and Primary Malignant Brain Tumor Risk in Type 2 Diabetes
9:12 AM - 9:19 AM
